CTOs on the Move

Health Fitness Corporation

www.hfit.com

 
HealthFitness is an award-winning provider of integrated health and fitness management services for employees and individuals.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.hfit.com
  • 1650 W 82nd St Ste 1100
    Minneapolis, MN USA 55431
  • Phone: 952.831.6830

Executives

Name Title Contact Details

Similar Companies

TRS Healthcare

TRS Healthcare is a healthcare staffing company that provides temporary nursing and allied health professionals to facilities across the United States.

Genuine Health Group

Healthcare industry veterans Joe Caruncho – whose success at the helm of Preferred Care Partners led to annual sales in excess of $750 million – and Orlando Lopez-Fernandez, Jr., MD, founded Genuine Health Group to usher in a new era of healthcare delivery focused on value instead of volume. Today, Genuine Health is building a model for managing care delivery that embodies traditional values, promises reliability, and embraces flexibility and technology. Through its accountable care organization, PremierMD ACO, the company aims to improve healthcare outcomes, achieve cost savings for the care of patients who receive traditional, fee-for-service Medicare benefits, and serve as a single point of contact to move doctors` Medicare members into value-based care. And, through its management service organization (MSO), the company aims to deliver financial upside for its participating physicians whose patients are enrolled in Medicare Advantage plans. For both traditional Medicare beneficiaries and those who choose managed care plans, Genuine Health and its providers are demonstrating the powerful effects of value-based care.

Orbus Therapeutics

Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.

Cenorin

Cenorin is a Kent, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wisteria Cottage

Wisteria Cottage is a Sequim, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.